|
Volumn 111, Issue 4, 2000, Pages 1122-1129
|
Defibrotide for the treatment of hepatic veno-occlusive disease: Results of the European compassionate-use study
|
Author keywords
Defibrotide; DNA aptamer; Multiorgan failure; Stem cell transplantation; Veno occlusive disease
|
Indexed keywords
DEFIBROTIDE;
ADOLESCENT;
ADULT;
AGED;
ARTICLE;
CHILD;
CLINICAL ARTICLE;
DISEASE COURSE;
EUROPE;
FEMALE;
HIGH RISK POPULATION;
HUMAN;
LIVER VENOOCCLUSIVE DISEASE;
MALE;
MULTIPLE ORGAN FAILURE;
PRIORITY JOURNAL;
RISK ASSESSMENT;
STEM CELL TRANSPLANTATION;
TREATMENT OUTCOME;
ACUTE DISEASE;
ADOLESCENT;
ADULT;
BILIRUBIN;
BREAST NEOPLASMS;
CHILD;
CHILD, PRESCHOOL;
FEMALE;
FIBRINOLYTIC AGENTS;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HEPATIC VENO-OCCLUSIVE DISEASE;
HODGKIN DISEASE;
HUMANS;
INFANT;
LEUKEMIA, LYMPHOCYTIC, ACUTE;
LEUKEMIA, MYELOID;
MALE;
MIDDLE AGED;
MULTIPLE MYELOMA;
POLYDEOXYRIBONUCLEOTIDES;
POSTOPERATIVE COMPLICATIONS;
TREATMENT OUTCOME;
|
EID: 20244365292
PISSN: 00071048
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1365-2141.2000.02475.x Document Type: Article |
Times cited : (178)
|
References (22)
|